TrialDiabetes care2011

Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study.

Joshua I Barzilay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.